The Enterprise Value as of April 2026 (TTM) for Pelthos Therapeutics Inc. (PTHS) is 32.97M

According to Pelthos Therapeutics Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 32.97M. This represents a change of -6.91% compared to the average of 35.42M of the last 4 quarters.

Pelthos Therapeutics Inc. (PTHS) Historical Enterprise Value (quarterly & annually)

How has PTHS Enterprise Value performed in the past?

The mean historical Enterprise Value of Pelthos Therapeutics Inc. over the last ten years is 16.50M. The current 32.97M Enterprise Value has changed 19.89% with respect to the historical average. Over the past ten years (40 quarters), PTHS's Enterprise Value was at its highest in in the December 2025 quarter at 114.60M. The Enterprise Value was at its lowest in in the March 2024 quarter at 1.77M.

Pelthos Therapeutics Inc. (PTHS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Pelthos Therapeutics Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Pelthos Therapeutics Inc. (PTHS) Average Enterprise Value

How has PTHS Enterprise Value performed in the past?

The current Enterprise Value of Pelthos Therapeutics Inc. (PTHS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Pelthos Therapeutics Inc. (PTHS) Enterprise Value vs. Peers

How is PTHS’s Enterprise Value compared to its peers?

Pelthos Therapeutics Inc.’s Enterprise Value is greater than CASI Pharmaceuticals, Inc. (17.66M), greater than Lisata Therapeutics, Inc. (12.77M), less than Clearside Biomedical, Inc. (56.38M), greater than Kairos Pharma, Ltd. (7.48M), greater than Lexaria Bioscience Corp. (8.72M), greater than Passage Bio, Inc. (-5103309.00), greater than Lixte Biotechnology Holdings, Inc. (11.85M), greater than Enlivex Therapeutics Ltd. (18.40M), greater than MetaVia Inc. (-6853886.00), greater than Cingulate Inc. (26.45M),

Build a custom stock screener for Pelthos Therapeutics Inc. (PTHS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pelthos Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Pelthos Therapeutics Inc. (PTHS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Pelthos Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.